Return to Trial Database

HCRN-LUN15-299

Phase II Study of Nivolumab and Ramucirumab for Patients with Previously-Treated Mesothelioma: Hoosier Cancer Research Network LUN15-299

Status

Study Completed

Cancer Type(s)

Study Contact

Publications

Phase 2 Trial of Nivolumab and Ramucirumab for Relapsed Mesothelioma

Trial Locations

All sites in which the trial HCRN-LUN15-299 being conducted in.

No data was found